Corporate DisclosureIBP
IBP Corporate Disclosure — 1 January 2024
Announcement summary
- What happened
- IBP published a corporate disclosure on 1 January 2024. Read the full announcement for details.
- Company
- Indo-Bangla Pharmaceuticals Limited
- Announcement published
Original announcement
Emerging Credit Rating Limited (ECRL) has affirmed surveillance rating of the Company as "BBB" in the long term and "ST-3" in the short term along with a Stable outlook based on audited financial statements up to June 30, 2023, and other relevant quantitative as well as qualitative information up to the date of rating.
বাংলা অনুবাদ — BullBD
This is a BullBD translation of the published corporate disclosure.
ইমার্জিং ক্রেডিট রেটিং লিমিটেড (ECRL) 30 জুন, 2023 পর্যন্ত নিরীক্ষিত আর্থিক বিবৃতির উপর ভিত্তি করে একটি স্থিতিশীল দৃষ্টিভঙ্গির সাথে দীর্ঘমেয়াদে "BBB" এবং স্বল্প মেয়াদে "ST-3" হিসাবে কোম্পানির নজরদারি রেটিং নিশ্চিত করেছে এবং রেটিং তারিখ পর্যন্ত অন্যান্য প্রাসঙ্গিক পরিমাণগত পাশাপাশি গুণগত তথ্য।
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 65923d34edb49c4b75e10bfd
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from IBP
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.